Circumvention of cancer drug resistance is one of the major investigations in nanomedicine.In this regard,nanotechnology-based drug delivery has offered various implications.However,protein-based nanocarriers have bee...Circumvention of cancer drug resistance is one of the major investigations in nanomedicine.In this regard,nanotechnology-based drug delivery has offered various implications.However,protein-based nanocarriers have been a versatile choice compared to other nanomaterials,provided by their favorable characteristics and safety profiles.Specifically,albumin-based nanoparticles have been demonstrated to be an effective drug delivery system,owing to the inherent targeting modalities of albumin,through gp60-and SPARC-mediated receptor endocytosis.Furthermore,surface functionalization was exploited for active targeting,due to albumin’s abundance of carboxylic and amino groups.Stimuli-responsive drug release has also been pertained to albumin nano-systems.Therefore,albumin-based nanocarriers could potentially overcome cancer drug resistance through bypassing drug efflux,enhancing drug uptake,and improving tumor accumulation.Moreover,albumin nanocarriers improve the stability of various therapeutic cargos,for instance,nucleic acids,which allows their systemic administration.This review highlights the recent applications of albumin nanoparticles to overcome cancer drug resistance,the nano-fabrication techniques,as well as future perspectives and challenges.展开更多
文摘Circumvention of cancer drug resistance is one of the major investigations in nanomedicine.In this regard,nanotechnology-based drug delivery has offered various implications.However,protein-based nanocarriers have been a versatile choice compared to other nanomaterials,provided by their favorable characteristics and safety profiles.Specifically,albumin-based nanoparticles have been demonstrated to be an effective drug delivery system,owing to the inherent targeting modalities of albumin,through gp60-and SPARC-mediated receptor endocytosis.Furthermore,surface functionalization was exploited for active targeting,due to albumin’s abundance of carboxylic and amino groups.Stimuli-responsive drug release has also been pertained to albumin nano-systems.Therefore,albumin-based nanocarriers could potentially overcome cancer drug resistance through bypassing drug efflux,enhancing drug uptake,and improving tumor accumulation.Moreover,albumin nanocarriers improve the stability of various therapeutic cargos,for instance,nucleic acids,which allows their systemic administration.This review highlights the recent applications of albumin nanoparticles to overcome cancer drug resistance,the nano-fabrication techniques,as well as future perspectives and challenges.
